Kolexia
Oudard Stephane Oncologie médicale
Oudard Stephane
Oncologie médicale
Hôpital Européen Georges Pompidou
Paris, France
798 Activités
567 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carcinomes Néphrocarcinome Tumeurs du rein Tumeurs prostatiques résistantes à la castration Métastase tumorale Tumeurs osseuses Tumeurs de la vessie urinaire Adénocarcinome

Collaborateurs

Voir plus
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France
Vano Yann-Alexandre
Vano Yann-Alexandre
Hôpital Européen Georges Pompidou, Paris, France
Escudier Bernard
Escudier Bernard
Gustave-Roussy, Villejuif, France
Thibault Constance
Thibault Constance
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Janssen
64 collaboration(s)
Dernière en 2023
Ipsen
44 collaboration(s)
Dernière en 2023
Edimark
24 collaboration(s)
Dernière en 2022
Bayer
22 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
NEMIO: NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab (MEDI4736) and Tremelimumab in Muscle-invasive Urothelial Carcinoma
Essai Clinique (Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie)   05 mars 2024
SPARTAN: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer
Essai Clinique (Aragon Pharmaceuticals, Inc.)   27 février 2024
Nivolumab immunotherapy rechallenge for progressive laryngeal squamous cell carcinoma after failure of conventional treatment: A CARE case report.
European annals of otorhinolaryngology, head and neck diseases   27 février 2024
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC): A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Essai Clinique (Aragon Pharmaceuticals, Inc.)   27 février 2024
TITAN: A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Essai Clinique (Aragon Pharmaceuticals, Inc.)   27 février 2024
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Clinical cancer research : an official journal of the American Association for Cancer Research   23 février 2024
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA.
JCO clinical cancer informatics   19 février 2024
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004): An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel Lindau Disease-Associated Renal Cell Carcinoma
Essai Clinique (Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA))   16 février 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
British journal of cancer   25 janvier 2024
PAXIPEM: Multicenter Phase II Study of Axitinib +/- Pembrolizumab in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC)
Essai Clinique (Centre Léon-Bérard)   24 janvier 2024